Treatment escalation and de-escalation decisions in Crohn's disease: Delphi consensus recommendations from Japan, 2021

H Nakase, M Esaki, F Hirai, T Kobayashi… - Journal of …, 2023 - Springer
Background We aimed to develop criteria for treatment intensification in patients with (1)
luminal Crohn's disease (CD),(2) CD with perianal disease and/or fistula,(3) CD with small …

The overall quality of evidence of recommendations surrounding nutrition and diet in inflammatory bowel disease

S Weissman, BM Fung, A Bangolo, A Rashid… - International Journal of …, 2023 - Springer
Background and aim Recently, there has been an increased focus on the role nutrition and
diet play in maintaining health in inflammatory bowel disease (IBD). We aimed to assess the …

[HTML][HTML] Pivot to Asia: inflammatory bowel disease burden

P Singh, A Ananthakrishnan, V Ahuja - Intestinal research, 2017 - synapse.koreamed.org
Inflammatory bowel disease (IBD) is a chronic, relapsing, inflammatory disorder of the
gastrointestinal tract, and includes UC and CD. IBD results from a combination of genetic …

NUDT15 C415T variant compared with TPMT genotyping in predicting azathioprine‐induced leucopenia: prospective analysis of 1014 inflammatory bowel disease …

R Banerjee, VV Ravikanth, P Pal, G Bale… - Alimentary …, 2020 - Wiley Online Library
Background Recent studies reported that Nudix Hydrolase 15 (NUDT 15) gene variant
(C415T) can better predict thiopurine induced leucopenia in Asian patients with …

Long‐term safety and effectiveness of azathioprine in the management of inflammatory bowel disease: A real‐world experience

RV Yewale, BS Ramakrishna, BV Doraisamy… - JGH …, 2023 - Wiley Online Library
Abstract Background and Aim Azathioprine (AZA) forms the cornerstone for maintenance of
sustained remission in inflammatory bowel disease (IBD). There is apprehension regarding …

Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South‐East Asia, and Middle East: preliminary findings from the …

R Banerjee, P Pal, I Hilmi, UC Ghoshal… - Journal of …, 2022 - Wiley Online Library
Abstract Background and Aim Inflammatory bowel disease (IBD) is emerging in the newly
industrialized countries of South Asia, South‐East Asia, and the Middle East, yet …

Perianal fistulizing Crohn's disease: Current perspectives on diagnosis, monitoring and management with a focus on emerging therapies

J Devi, DH Ballard, T Aswani-Omprakash… - Indian Journal of …, 2024 - Springer
Abstract Crohn's disease (CD), a chronic inflammatory bowel disorder, manifests in various
phenotypes, with fistulizing perianal CD (CD-PAF) being one of its most severe phenotypes …

[HTML][HTML] Cirsimaritin alleviates dextran sodium sulfate-induced acute colitis in experimental animals: A therapeutic approach for inflammatory bowel disease

A Alqudah, E Qnais, O Gammoh, Y Bseiso… - … Nutrition and Food …, 2024 - ncbi.nlm.nih.gov
Inflammatory bowel disease (IBD) is a chronic disease that affects the entire digestive tract.
IBD can be classified as ulcerative colitis or Crohn's disease. The key symptoms of IBD …

Cost of illness in inflammatory bowel disease

N Kamat, C Ganesh Pai, M Surulivel Rajan… - Digestive Diseases and …, 2017 - Springer
Background Frequent relapses sometimes necessitating hospitalization and the absence of
pharmacological cure contribute to substantial healthcare costs in inflammatory bowel …

Long-term outcomes in perianal fistulizing Crohn's disease in a resource-limited setting: a cohort analysis

SK Vuyyuru, P Sahu, S Kedia, B Kante, P Kumar… - Indian Journal of …, 2020 - Springer
Background Perianal fistula is one of the most challenging complications of Crohn's disease
(CD). We aimed to describe treatment response with surgical and medical therapies, and …